Covid, Paxlovid
Despite Previous Data, Paxlovid May Be Useful for Long Covid After All
These findings counter clinical trial results published in June which found that Paxlovid was safe to take but did not lessen long COVID symptoms, the UCSF researchers noted. Those earlier trial results, based on data from 155 patients, appeared in the journal JAMA Internal Medicine.
Paxlovid may help some long COVID patients: Research
A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid during a SARS-CoV-2 infection has previously been linked to a lower risk of developing long COVID symptoms.
But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who ...
The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts.
Enanta Pharmaceuticals plans to appeal a court decision that Pfizer's Covid-19 antiviral drug, Paxlovid, doesn't infringe on its own patents. The U.S. District Court of Massachusetts ruled that Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback